Equity/Index & Cross Asset Volatility Specialist, Cameron Design

Jay Cameron

With nearly two decades of experience across sell side and brokerage platforms, I specialize in quantitative research on equity derivatives and cross-asset strategies. My work focuses on translating market data into volatility-centered frameworks—integrating fundamental views, statistical models, technical analysis, Artificial Intelligence, and trading intuition to identify asymmetries and quantitative driven opportunities. I cover Japan and US with an emphasis on hedged dispersion style trades, correlation, complementing long-short ideas.  Noting my recent co-founder/advisor role in a US startup, my area of expertise also includes memory solutions for Artificial Intelligence.

Equity/Index & Cross Asset Volatility Specialist

AEON (8267) Restructuring Strategy: Monetize Volatility After Tsuruha-Welcia Consolidation, 237xP/E

[Japan Activism/M&A] Thinking About the Partial Tender Trade Coming in Dec25

[Japan Activism/M&A] - Closing In On the Tsuruha Partial Tender - Likely Needs To Be Higher

[Japan Activism/M&A] - Shareholders Approve Tsuruha/Welcia Merger - Now It's Partial Offer+Synergies

Cameron Design

We specialize in financial products and volatility. Our strategies balance speed, data, and risk control to capture opportunities across global markets. Our research leverages AI and data analytics to continuously refine our algorithms and adapt to evolving market dynamics.

Event-Driven

<ul>
<li>The Tsuruha-Welcia merger creates Japan's largest drugstore alliance, poised for long-term growth and market dominance, driven by an expected JPY 50B in synergies over three years.</li>
<li>A two-step corporate action—share exchange (Dec 1, 2025) followed by an Aeon TOB—provides structural certainty and strategic backing, securing the combined entity's market leadership.</li>
<li>These catalysts establish a large market leader in the consumer staples space, suggesting a timely opportunity to gain exposure to the new entity.</li>
</ul>


The Tsuruha-Welcia merger creates Japan's largest drugstore alliance, poised for long-term growth and market dominance, driven by an expected JPY 50B in synergies over three years.
A two-step corporate action—share exchange (Dec 1, 2025) followed by an Aeon TOB—provides structural certainty and strategic backing, securing the combined entity's market leadership.
These catalysts establish a large market leader in the consumer staples space, suggesting a timely opportunity to gain exposure to the new entity.


Tsuruha-Welcia Merger to Form Biggest Drugstore Alliance, +Aeon TOB

Tsuruha Holdings

Tsuruha-Welcia Merger to Form Biggest Drugstore Alliance, +Aeon TOB